The 14 analysts offering 12-month price forecasts for Axsome Therapeutics Inc have a median target of 147.50, with a high estimate of 210.00 and a low estimate of 65.00. The median estimate represents a +91.93% increase from the last price of 76.85.
The current consensus among 14 polled investment analysts is to Buy stock in Axsome Therapeutics Inc. This rating has held steady since January, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$0.75
Reporting Date Mar 18
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.